Exo Therapeutics
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- $103M
Investors
- 9
About Exo Therapeutics
Exo Therapeutics, Inc.Founded in 2018 and headquartered in Cambridge, US, Exo Therapeutics, Inc. develops transformative therapies targeting intractable drug targets.Exo Therapeutics, Inc. specializes in innovative therapies targeting intractable drug targets through its proprietary ExoSight™ platform. The company’s core product offerings include exosite inhibitors, particularly the EXO-TBKi, which disrupts STING-mediated TBK1 activation linked to inflammatory conditions and oncology applications.Exo Therapeutics generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research organizations. Their business model primarily revolves around B2B agreements, which may include licensing agreements or co-development deals for utilizing Exo Therapeutics' exosite inhibitors.Exo Therapeutics, Inc.82 mn to further develop treatment concepts in cancer and inflammation using its ExoSight™ technology, advancing them to proof-of-concept and clinical trials. The company aims to explore additional targets with the ExoSight platform. Future expansion efforts include entering new markets in Asia and Europe by 2023, enhancing their geographical footprint and addressing unmet medical needs.
Who invested in Exo Therapeutics
9 investors across 2 rounds
See all investors in Exo Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Exo Therapeutics
Who invested in Exo Therapeutics?
Exo Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Exo Therapeutics raised?
Exo Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Exo Therapeutics last raise money?
Exo Therapeutics's most recent round on record is a Series B, in Oct 2021.
What does Exo Therapeutics do?
Exo Therapeutics is a biotechnology company.
Where is Exo Therapeutics headquartered?
Exo Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Exo Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Exo Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Exo Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.